71
TÍTULO: Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison
AUTORES: Maung, HM; Elangovan, L; Frazao, JM ; Bower, JD; Kelley, BJ; Acchiardo, SR; Rodriguez, HJ; Norris, KC; Sigala, JF; Rutkowski, M; Robertson, JA; Goodman, WG; Levine, BS; Chesney, RW; Mazess, RB; Kyllo, DM; Douglass, LL; Bishop, CW; Coburn, JW;
PUBLICAÇÃO: 2001, FONTE: AMERICAN JOURNAL OF KIDNEY DISEASES, VOLUME: 37, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef: 71
72
TÍTULO: A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism  Full Text
AUTORES: Goodman, WG; Frazao, JM ; Goodkin, DA; Turner, SA; Liu, W; Coburn, JW;
PUBLICAÇÃO: 2000, FONTE: KIDNEY INTERNATIONAL, VOLUME: 58, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef: 133
73
TÍTULO: Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism
AUTORES: Frazao, JM ; Elangovan, L; Maung, HM; Chesney, RW; Acchiardo, SR; Bower, JD; Kelley, BJ; Rodriguez, HJ; Norris, KC; Robertson, JA; Levine, BS; Goodman, WG; Gentile, D; Mazess, RB; Kyllo, DM; Douglass, LL; Bishop, CW; Coburn, JW;
PUBLICAÇÃO: 2000, FONTE: AMERICAN JOURNAL OF KIDNEY DISEASES, VOLUME: 36, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef: 98
74
TÍTULO: Calcium-sensing receptor and calcimimetic agents
AUTORES: Coburn, JW; Elangovan, L; Goodman, WG; Frazao, JM ;
PUBLICAÇÃO: 1999, FONTE: Kidney International, Supplement, VOLUME: 56, NÚMERO: 73
INDEXADO EM: Scopus
75
TÍTULO: Calcium-sensing receptor and calcimimetic agents  Full Text
AUTORES: Coburn, JW; Elangovan, L; Goodman, WG; Frazao, JM ;
PUBLICAÇÃO: 1999, FONTE: Symposium on Renal Bone Disease in KIDNEY INTERNATIONAL, VOLUME: 56
INDEXADO EM: WOS CrossRef: 32
77
TÍTULO: Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure
AUTORES: Frazao, JM ; Elangovan, L; Felsenfeld, AJ; Stanley, TM; Cohen, AH;
PUBLICAÇÃO: 1998, FONTE: NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 13, NÚMERO: 7
INDEXADO EM: Scopus WOS CrossRef: 11
78
TÍTULO: Hypokinetic azotemic osteodystrophy  Full Text
AUTORES: Cannata Andia, JB; Harrington, JT; Martinez Maldonado, M; Massari, P; Schor, N; Carlos Ayus, J; Valderrabano, F; Frazao, J ; Coburn, JW; Weisinger, JR; Heilberg, IP; Ferreira, A ;
PUBLICAÇÃO: 1998, FONTE: Kidney International, VOLUME: 54, NÚMERO: 3
INDEXADO EM: Scopus CrossRef: 44
79
TÍTULO: Intermittent oral 1 alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients
AUTORES: Frazao, JM ; Chesney, RW; Coburn, JW;
PUBLICAÇÃO: 1998, FONTE: 2nd International Symposium on Advances in Renal Osteodystrophy in NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 13, NÚMERO: SUPPL. 3
INDEXADO EM: Scopus WOS CrossRef: 38
80
TÍTULO: Efficacy and safety of intermittent oral 1 alpha(OH) vitamin D-2 in suppressing 2 degrees hyperparathyroidism in hemodialysis patients  Full Text
AUTORES: Frazao, JM ; Levine, BS; Tan, AU; Mazess, RB; Kyllo, DM; Knutson, JC; Bishop, CW; Coburn, JW;
PUBLICAÇÃO: 1997, FONTE: 29th Annual Meeting of the American-Society-of-Nephrology in DIALYSIS & TRANSPLANTATION, VOLUME: 26, NÚMERO: 9
INDEXADO EM: Scopus WOS
Página 8 de 9. Total de resultados: 85.